Emergence of Antimicrobial Resistance among Pseudomonas aeruginosa: Implications for Therapy

Joseph P Lynch1, George G Zhanel2, Nina M Clark3

  • 1Division of Pulmonary, Critical Care Medicine, Allergy, and Clinical Immunology, Department of Medicine, David Geffen School of Medicine, UCLA, Los Angeles, California.

Insights

Pseudomonas aeruginosa (PA) causes severe hospital infections, especially in vulnerable patients. Rising antimicrobial resistance makes treating PA difficult, increasing mortality risks.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Pseudomonas aeruginosa (PA) is a Gram-negative bacillus frequently causing nosocomial infections in critically ill patients.
  • PA infections occur in ventilator-associated pneumonia (VAP), bloodstream, urinary tract, and wound infections, posing significant challenges.
  • Intrinsic and acquired antimicrobial resistance complicates treatment, leading to high mortality rates, particularly for VAP and bacteremia.

Purpose of the Study:

  • To review the emergence and global escalation of antimicrobial resistance in Pseudomonas aeruginosa.
  • To discuss current and future therapeutic strategies for managing PA infections.

Main Methods:

  • Literature review focusing on antimicrobial resistance trends in Pseudomonas aeruginosa.
  • Analysis of treatment approaches for pseudomonal infections, including empirical and definitive therapies.

Main Results:

  • Antimicrobial resistance in PA has significantly increased globally over the past three decades.
  • Multidrug-resistant epidemic clones of PA have disseminated internationally.
  • High mortality rates (>35%) are associated with pseudomonal VAP and bacteremias, with ongoing therapeutic controversies.

Conclusions:

  • The escalating antimicrobial resistance of Pseudomonas aeruginosa necessitates urgent attention and revised therapeutic strategies.
  • Effective management of PA infections requires a comprehensive approach addressing both resistance patterns and treatment options.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.7K
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
779
Antibiotic Selection00:57

Antibiotic Selection

Overview
61.0K
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
538
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
903
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
1.4K